Suppr超能文献

行胰十二指肠切除术的老年胰腺癌患者住院 30 天死亡率。

In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy.

机构信息

Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

出版信息

J Geriatr Oncol. 2020 May;11(4):660-667. doi: 10.1016/j.jgo.2019.10.012. Epub 2019 Nov 6.

Abstract

OBJECTIVE

Surgical resection remains the only potentially curative therapy for pancreatic ductal adenocarcinoma (PDAC). There is paucity of literature about morbidity and mortality in older patients with PDAC undergoing pancreaticoduodenectomy. This retrospective analysis evaluates the in-hospital 30-day mortality of this population utilizing the Nationwide Inpatient Sample (NIS) database.

SUBJECTS AND METHODS

All US patients hospitalized for pancreaticoduodenectomy (Whipple procedure) were included. Data was obtained from the NIS provided by the Agency for Healthcare Research and Quality. Pancreaticoduodenectomy diagnoses were identified using Clinical Classifications Software codes based on ICD-9 between 2007 and 2010. Univariable and multivariable analyses were performed using the logistic model, weighted chi-square test, and generalized linear model.

RESULTS

A total of 6149 patient discharges for pancreaticoduodenectomy were identified. Mean age was 64.9 years (SD ± 12.3); 21% of patients were ≥ 76 years of age. Majority were White (N = 5257, 77.9%) with a male:female ratio of 1. Patients aged 76 and older (OR: 1.76; 1.36-2.28; p < .001), Hispanics (OR: 1.40; 0.92-2.13; p = .12), and high comorbidity score (OR: 5.70; 3.44-9.46; p < .001) were found to be associated with a higher risk of 30-day in-hospital mortality. In the multivariable analysis, advanced age (>76) remained a significant predictor of longer in-hospital length of stay (OR: 1.09; 1.04-1.14; p < .001) and 30-day in-hospital mortality (OR 1.46; 1.07-2.00; p = .016). The 30-day in-hospital mortality rate for all patients across all years was 3.24%, for patients >76 years 4.11% and for patients <76 years 2.77%. Patients who underwent surgery at teaching hospitals (OR: 0.61; 0.42-0.88; p = .008) had a lower risk of 30-day in-hospital mortality compared to non-teaching hospitals.

CONCLUSION

In-hospital 30 day mortality was higher in selected older patients with PDAC undergoing pancreaticoduodenectomy. Mortality was lower at high volume and teaching centers. Further stringent selection criteria are needed to decrease mortality in the older population.

摘要

目的

手术切除仍然是治疗胰腺导管腺癌(PDAC)的唯一潜在治愈性疗法。关于接受胰十二指肠切除术(PD)的老年 PDAC 患者的发病率和死亡率的文献很少。本回顾性分析利用全国住院患者样本(NIS)数据库评估了该人群的住院 30 天死亡率。

对象和方法

纳入所有因 PD 而行胰十二指肠切除术(Whipple 手术)住院的美国患者。数据来自医疗保险和医疗补助服务中心提供的 NIS。PD 诊断是根据 2007 年至 2010 年 ICD-9 中的临床分类软件代码确定的。使用逻辑模型、加权卡方检验和广义线性模型进行单变量和多变量分析。

结果

共确定 6149 例 PD 切除术患者出院。平均年龄为 64.9 岁(SD ± 12.3);21%的患者年龄≥76 岁。大多数为白人(N=5257,77.9%),男女比例为 1。76 岁及以上患者(OR:1.76;1.36-2.28;p<0.001)、西班牙裔(OR:1.40;0.92-2.13;p=0.12)和高合并症评分(OR:5.70;3.44-9.46;p<0.001)与 30 天住院内死亡率较高相关。多变量分析显示,高龄(>76 岁)仍是住院时间延长(OR:1.09;1.04-1.14;p<0.001)和 30 天住院内死亡率(OR 1.46;1.07-2.00;p=0.016)的显著预测因素。所有年份所有患者的 30 天院内死亡率为 3.24%,76 岁以上患者为 4.11%,76 岁以下患者为 2.77%。与非教学医院相比,在教学医院接受手术的患者(OR:0.61;0.42-0.88;p=0.008)30 天住院内死亡率较低。

结论

在接受胰十二指肠切除术的特定老年 PDAC 患者中,住院 30 天死亡率较高。在高容量和教学中心,死亡率较低。需要进一步严格的选择标准,以降低老年人群的死亡率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验